Macrolide-Resistant Group A Streptococcus Detected
This patient has Group A Streptococcus (Streptococcus pyogenes) pharyngitis with macrolide resistance genes that render erythromycin, azithromycin, clarithromycin, and clindamycin ineffective—you must treat with penicillin or amoxicillin instead.
What the Resistance Genes Mean
The detection of ermB and mefA genes indicates your patient harbors a strain with dual macrolide resistance mechanisms:
ermB gene: Encodes ribosomal methylation that confers the constitutive MLSb phenotype (Macrolide-Lincosamide-Streptogramin B resistance). This makes the bacteria resistant to erythromycin, azithromycin, clarithromycin, AND clindamycin 1, 2.
mefA gene: Encodes an efflux pump that confers the M phenotype, providing resistance to macrolides (erythromycin, azithromycin, clarithromycin) but traditionally sparing clindamycin 3, 2.
When both genes are present together (as in your patient), the ermB gene dominates the phenotype—meaning clindamycin will NOT work 1, 3.
Treatment Implications
First-Line Treatment
- Use penicillin V or amoxicillin for 10 days 4
- All GAS strains remain universally susceptible to penicillin with no resistance reported 5, 3, 2
- This is the only reliable antibiotic choice for your patient
What NOT to Use
- Avoid all macrolides: erythromycin, azithromycin, clarithromycin
- Avoid clindamycin: Despite mefA typically sparing clindamycin, the presence of ermB makes it ineffective
- Recent data from West Virginia showed 76% of invasive GAS isolates were simultaneously resistant to both erythromycin and clindamycin, with ermB being a major contributor 6
Clinical Context
Resistance Prevalence
The overall macrolide resistance rate in the U.S. ranges from 3.5-6.8% 5, 2, but this varies dramatically by region. Recent surveillance from West Virginia documented resistance rates as high as 76% in invasive disease 6, while other regions remain lower.
Why This Matters for Treatment
- Macrolide resistance doesn't affect the need to treat—GAS pharyngitis still requires antibiotics to prevent acute rheumatic fever, peritonsillar abscess, and transmission 4
- The 2012 IDSA guidelines recommend treating all confirmed GAS pharyngitis for 10 days with appropriate narrow-spectrum antibiotics 4
- Penicillin allergy patients: Consider cephalosporins (if no anaphylaxis history) rather than macrolides for this patient
Resistance Gene Distribution
Studies show ermB is frequently associated with constitutive resistance and has been detected in 8.5-93.85% of resistant strains depending on geographic region 1, 2, 7. The mefA gene appears in 43-48% of resistant isolates 3, 2. Co-carriage of both genes (as in your patient) occurs in approximately 13-22% of resistant strains 1, 3.
Key Pitfall to Avoid
Do not assume clindamycin will work just because mefA is present. The simultaneous detection of ermB overrides any potential clindamycin susceptibility. If you need an alternative to penicillin, perform formal susceptibility testing or use a cephalosporin rather than empirically choosing clindamycin 6.